Oncology moves fast. so do we.
Fighting Cancer
One Word at a Time
Trusted updates, insights, and resources for clinicians and educators.
Get the Latest
Oncology News
Breaking oncology updates, FDA decisions, and expert perspectives from the Cancer Communicator team.
-
QuickView: Sunvozertinib vs Chemotherapy in Advanced EGFR exon20ins NSCLC (WU-KONG28)
First-line sunvozertinib prolongs PFS in EGFR exon 20 insertion–mutated advanced NSCLC
-
#ASCO26 News: Teclistamab Monotherapy Improves PFS and OS in Early RRMM
Results from the phase 3 MajesTEC-9 trial, presented on Day 1 of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, showed that teclistamab monotherapy significantly improved…
-
#ASCO26: First-Line Sunvozertinib Prolongs PFS in EGFR Exon 20 Insertion–Mutated Advanced NSCLC
The oral EGFR tyrosine kinase inhibitor sunvozertinib significantly improved progression-free survival (PFS) compared with carboplatin–pemetrexed as first-line treatment for advanced nonsquamous non–small cell lung cancer (NSCLC) with epidermal…
-
FDA Approves Pivekimab Sunirine for BPDCN
On May 27, 2026, the U.S. Food and Drug Administration (FDA) approved pivekimab sunirine-pvzy (Decnupaz), a CD123-directed antibody-drug conjugate delivering a DNA alkylating payload, for the treatment of…
-
Aspiring doctors may need to find another quarter million dollars to go to school
Workforce access · Federal student loan reform Aspiring doctors may need to find another quarter million dollars to go to school. The federal funding gap created by the…
-
ASCO GU 2026: Perioperative EV/Pembrolizumab Outperforms Gemcitabine/Cisplatin in MIBC
At the 2026 ASCO Genitourinary Cancers Symposium, Matthew D. Galsky, MD, presented results from the phase 3 KEYNOTE-B15 study showing that perioperative enfortumab vedotin plus pembrolizumab improved outcomes…
Counting Down
ASCO Annual Meeting 2026
May 29 – June 2 · McCormick Place, Chicago
Watch for Cancer Communicator coverage from Chicago.
Don't Miss
Upcoming Conferences
Improving outcomes with the latest evidence.
ASCO Annual Meeting 2026
May 29 - June 2EACR 2026 Congress
June 8 - June 11EHA2026 Congress
June 11 - June 14ESMO Targeted Anticancer Therapies Asia Congress 2026
June 12 - June 14ESMO Gynaecological Cancers Congress 2026
June 17 - June 19MASCC/ISOO Annual Meeting 2026
June 25 - June 27
Watch
Featured Series
Video Podcast
Oncology Unscripted with Dr John Marshall
Move over John Oliver and meet Dr John Marshall. Cancer Communicator is proud to partner with Dr Marshall and Decera Clinical Insights to produce this long-running candid program about the changing oncology world. Honest, timely, occasionally hilarious conversations on the people, policy, and science shaping oncology care.
Patient and clinician education
MyCancerHaven
MyCancerHaven was founded by Dr Ravi Vij, a renowned multiple myeloma leader and long-time collaborator. Cancer Communicator partners with MCH to produce educational video series for patients with hematologic malignancies. Check out our most recent series focusing on chronic lymphocytic leukemia.